Literature DB >> 32232837

Headaches Associated With Personal Protective Equipment - A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19.

Jonathan J Y Ong1,2, Chandra Bharatendu1,2, Yihui Goh1, Jonathan Z Y Tang2,3, Kenneth W X Sooi1, Yi Lin Tan1, Benjamin Y Q Tan1,2, Hock-Luen Teoh1,2, Shi T Ong3, David M Allen2,4, Vijay K Sharma1,2.   

Abstract

BACKGROUND: Coronavirus disease 2019 (COVID-19) is an emerging infectious disease of pandemic proportions. Healthcare workers in Singapore working in high-risk areas were mandated to wear personal protective equipment (PPE) such as N95 face mask and protective eyewear while attending to patients.
OBJECTIVES: We sought to determine the risk factors associated with the development of de novo PPE-associated headaches as well as the perceived impact of these headaches on their personal health and work performance. The impact of COVID-19 on pre-existing headache disorders was also investigated.
METHODS: This is a cross-sectional study among healthcare workers at our tertiary institution who were working in high-risk hospital areas during COVID-19. All respondents completed a self-administered questionnaire.
RESULTS: A total of 158 healthcare workers participated in the study. Majority [126/158 (77.8%)] were aged 21-35 years. Participants included nurses [102/158 (64.6%)], doctors [51/158 (32.3%)], and paramedical staff [5/158 (3.2%)]. Pre-existing primary headache diagnosis was present in about a third [46/158 (29.1%)] of respondents. Those based at the emergency department had higher average daily duration of combined PPE exposure compared to those working in isolation wards [7.0 (SD 2.2) vs 5.2 (SD 2.4) hours, P < .0001] or medical ICU [7.0 (SD 2.2) vs 2.2 (SD 0.41) hours, P < .0001]. Out of 158 respondents, 128 (81.0%) respondents developed de novo PPE-associated headaches. A pre-existing primary headache diagnosis (OR = 4.20, 95% CI 1.48-15.40; P = .030) and combined PPE usage for >4 hours per day (OR 3.91, 95% CI 1.35-11.31; P = .012) were independently associated with de novo PPE-associated headaches. Since COVID-19 outbreak, 42/46 (91.3%) of respondents with pre-existing headache diagnosis either "agreed" or "strongly agreed" that the increased PPE usage had affected the control of their background headaches, which affected their level of work performance.
CONCLUSION: Most healthcare workers develop de novo PPE-associated headaches or exacerbation of their pre-existing headache disorders.
© 2020 American Headache Society.

Entities:  

Keywords:  N95; coronavirus disease; coronavirus disease 2019; eyewear; face mask; goggles; headache; healthcare workers; personal protection equipment (PPE)

Mesh:

Year:  2020        PMID: 32232837     DOI: 10.1111/head.13811

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  107 in total

Review 1.  Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?

Authors:  Kai Kisielinski; Paul Giboni; Andreas Prescher; Bernd Klosterhalfen; David Graessel; Stefan Funken; Oliver Kempski; Oliver Hirsch
Journal:  Int J Environ Res Public Health       Date:  2021-04-20       Impact factor: 3.390

2.  Headaches Associated with Face Mask Use During COVID-19 Pandemic-Are We Seeing a Headache Epidemic?

Authors:  Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-05-20

3.  The lived experiences of frontline nurses during the coronavirus disease 2019 (COVID-19) pandemic in Qatar: A qualitative study.

Authors:  Ralph C Villar; Abdulqadir J Nashwan; Rejo G Mathew; Ahmed S Mohamed; Sathish Munirathinam; Ahmad A Abujaber; Mahmood M Al-Jabry; Mujahed Shraim
Journal:  Nurs Open       Date:  2021-05-05

4.  Adherence to Masking Requirement During the COVID-19 Pandemic by Early Elementary School Children.

Authors:  Geoffrey E Mickells; Janet Figueroa; Kelly Withers West; Anna Wood; Barbara O McElhanon
Journal:  J Sch Health       Date:  2021-05-16       Impact factor: 2.118

5.  The intersection of COVID-19, school, and headaches: Problems and solutions.

Authors:  Dina Karvounides; Maya Marzouk; Alexandra C Ross; Juliana H VanderPluym; Christina Pettet; Ali Ladak; Jason Ziplow; Carlyn Patterson Gentile; Scott Turner; Marissa Anto; Rebecca Barmherzig; Madeline Chadehumbe; Jocelyn Kalkbrenner; Carrie P Malavolta; Michelle A Clementi; Trevor Gerson; Christina L Szperka
Journal:  Headache       Date:  2020-12-31       Impact factor: 5.887

Review 6.  [Make nursing practice visible through nursing science in times of COVID-19].

Authors:  Manuela Hödl; Silvia Bauer; Doris Eglseer; Martin Fangmeyer; Magdalena Flatscher-Thöni; Jan Kellerer; Christiane Kreyer; Gerhard Müller; Martin Pallauf; Matthias Rohringer; Ana Toromanova; Daniela Schoberer
Journal:  Wien Med Wochenschr       Date:  2021-07-01

Review 7.  Adverse Effects of Personal Protective Equipment Among Intensive Care Unit Healthcare Professionals During the COVID-19 Pandemic: A Scoping Review.

Authors:  Takeshi Unoki; Hideaki Sakuramoto; Ryuhei Sato; Akira Ouchi; Tomoki Kuribara; Tomomi Furumaya; Junko Tatsuno; Yuki Wakabayashi; Asami Tado; Naoya Hashimoto; Noriko Inagaki; Yoshiko Sasaki
Journal:  SAGE Open Nurs       Date:  2021-06-17

8.  Personal protective equipment for Health care workers donning for COVID-19 areas: Walking a tight rope between safety and comfort!

Authors:  Anju Gupta; Nishkarsh Gupta
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2021-07-15

9.  Overall trend towards headache remission during the COVID-19 pandemic among Chinese patients with pre-existing headache highlights the role of family support.

Authors:  Qiaoyu Gong; Shuping Liu; Ruiting Li; Lihua Yao; Zheman Xiao
Journal:  BMC Neurol       Date:  2021-06-15       Impact factor: 2.474

10.  Face Masks in Young Children During the COVID-19 Pandemic: Parents' and Pediatricians' Point of View.

Authors:  Rémy Assathiany; Catherine Salinier; Stéphane Béchet; Claire Dolard; Fabienne Kochert; Alain Bocquet; Corinne Levy
Journal:  Front Pediatr       Date:  2021-06-23       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.